エピソード

  • Optimizing the Right Team for the Right Moment

    Optimizing the Right Team for the Right Moment
    2024/06/12
    Episode two of "The Power of Persistence" delves into the vital role that people play in the success of biotech companies. Host Jennifer LW Fink is joined by Holly May, President of BioLineRx US, who shares insights on building and optimizing the right team for a biotech startup. Holly emphasizes the importance of hiring the right people, nurturing their development, and fostering a culture of growth and innovation. The episode explores the challenges of scaling up a company's team while maintaining a focus on purpose and culture.
    続きを読む 一部表示
    22 分
  • From Incubation to Laser-Focused Biotech Innovation

    From Incubation to Laser-Focused Biotech Innovation
    2024/06/05
    In the inaugural episode, we explore the origins of BioLineRx and its transformation from a biotech incubator to a fully-fledged biotech company. Joined by Phil Serlin, CEO of BioLineRx, we uncover the company's early days, its broad pipeline spanning various therapeutic areas, and the strategic decision-making process that led to its evolution. From strategic evaluations to pivoting towards oncology and hematology, this episode highlights the importance of persistence and strategic adaptability in the biotech industry.
    続きを読む 一部表示
    20 分
  • Looking Ahead: Pipeline Development

    Looking Ahead: Pipeline Development
    2024/06/05
    Episode three of "The Power of Persistence" focuses on pipeline development in the biotech industry. Phil Serlin, CEO of BioLineRX, discusses how companies balance launching one product while maintaining pipeline development. Phil emphasizes the versatility of their platform molecule and the various applications it offers, such as stem cell mobilization for different transplantation types and gene therapy. Phil shares insights into how BioLineRX identifies potential partners and leverages existing expertise to expand their pipeline strategically. The discussion underscores the dynamic nature of the biotech industry and the need for companies to seize the moment while preparing for the future.
    続きを読む 一部表示
    16 分